ArticleScientific reports2025

Identifying robust biomarkers for the diagnosis and subtype distinction of inflammatory bowel disease through comprehensive serum metabolomic profiling.

Ji Eun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.